Glioblastomas with giant cell and sarcomatous features in patients with turcot syndrome type 1: A clinicopathological study of 3 cases

Neurosurgery

Volumn 67, Issue 3, 2010, Pages 811-817

  Lusis, Eriks A ^a   Travers, Sarah ^a   Jost, Sarah C ^b   Perry, Arie ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

Author keywords

Fluorescence in situ hybridization; Giant cell glioblastoma; Gliosarcoma; Prognosis; Tumor genetics; Turcot syndrome

Indexed keywords

CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOCITRATE DEHYDROGENASE; KI 67 ANTIGEN; LOMUSTINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROCARBAZINE; RETICULIN; TEMOZOLOMIDE; VINCRISTINE;

ADULT; CASE REPORT; CRANIOTOMY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GIANT CELL; GLIOBLASTOMA; GLIOSARCOMA; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; LAMINECTOMY; MALE; MITOSIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SARCOMA CELL; SURVIVAL TIME; TURCOT SYNDROME;

BRAIN NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GIANT CELLS; GLIOBLASTOMA; GLIOSARCOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; RETROSPECTIVE STUDIES; SARCOMA; YOUNG ADULT;

EID: 77956182472     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000375513.12925.5C     Document Type: Review

References (43)

1. Turcot J, Despres J P, St Pierre F. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum. 1959;2:465-468.
2. Agostini M, Tibiletti MG, Lucci-Cordisco E, et al. Tw o PMS2 mutations in a Turcot syndrome family with small bowel cancers. Am J Gastroenterol. 2005;100(8): 1886-1891.
3. Hegde MR, Chong B, Blazo ME, et al. A homozygous mutation in MSH6 causes Turcot syndrome. Clin Cancer Res. 2005;11(13):4689-4693.
4. Taylor MD, Perry J, Zlatescu MC, et al. The hPMS2 exon 5 mutation and malignant glioma. Case report. J Neurosurg. 1999;90(5):946-950.
5. Gottschling S, Reinhard H, Pagenstecher C, et al. Hypothesis: possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defects. Eur J Pediatr. 2008;167(2):225-229.
6. De Vos M, Hayward BE, Picton S, Sheridan E, Bonthron D T. Novel PMS2 pseudo-genes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet. 2004;74(5):954-964.
7. Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: two genetic diseases? J Clin Oncol. 1997;15(7):2744-2758.
8. Tamiya T, Hamazaki S, Ono Y, et al Ganglioglioma in a patient with Turcot syndrome. Case report. J Neurosurg. 2000;92(1):170-175.
9. Mullins KJ, Rubio A, Myers S P, Korones DN, Pilcher WH. Malignant ependy-momas in a patient with Turcot's syndrome: case report and management guidelines. Surg Neurol. 1998;49(3):290-294.
10. Biernat W, Aguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol. 1995;54(5):651-656.
11. Galanis E, Buckner JC, Dinapoli R P, et al. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: north central cancer treatment group results. J Neurosurg. 1998;89(3):425-430.
12. Meis JM, Martz KL, Nelson JS. Mixed glioblastoma multiforme and sarcoma. A clinicopathologic study of 26 radiation therapy oncology group cases. Cancer. 1991;67(9):2342-2349.
13. Winkler PA, Buttner A, Tomezzoli A, Weis S. Histologically repeatedly confirmed gliosarcoma with long survival: review of the literature and report of a case. Acta Neurochir (Wien). 2000;142(1):91-95.
14. Deb P, Sharma MC, Chander B, Mahapatra AK, Sarkar C. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosar-coma. Childs Nerv Syst. 2006;22(3):314-319.
15. Kozak KR, Moody JS. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis. Neuro Oncol. 2009;11(6):833-841.
16. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med. 1995;332(13):839-847.
17. Merlo A, Rochlitz C, Scott R. Survival of patients with Turcot's syndrome and glioblastoma. N Engl J Med. 1996;334(11):736-737.
18. Bancroft JD. Theory and Practice of Histological Techniques. 4th ed. New York, NY: Churchill Livingstone Inc; 1996.
19. LG. L. Manual of Histological Staining Methods of the AFIP. 3rd ed. New York, NY: McGraw-Hill Book Company 1968.
20. Prophet EBMB, Arrington JB, Sobin LH. AFIP: Laboratory Methods in Histotechnology. 1st ed. Washington, DC: American Registry of Pathology; 1992.
21. Siegelin MD, Habel A, Gaiser T. 17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis. Neurobiol Dis. 2009;33(2):243-249.
22. Capper D, Weissert S, Balss J, et al. Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors. Brain Pathol. 2010;20(1):245-254.
23. Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol. 2009;118(5):599-601.
24. Perry A, Miller CR, Gujrati M, et al. Malignant gliomas with primitive neuroec-todermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain Pathol. 2009;19(1):81-90.
25. Eckert A, Kloor M, Giersch A, et al. Microsatellite instability in pediatric and adult high-grade gliomas. Brain Pathol. 2007;17(2):146-150.
26. Houillier C, Lejeune J, Benouaich-Amiel A, et al. Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer. 2006;106(10):2218-2223.
27. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170(5):1445-1453.
28. Tohma Y, Gratas C, Biernat W, et al. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol. 1998;57(7):684-689.
29. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci\USA. 1987;84(19):6899-6903.
30. Ekstrand AJ, Sugawa N, James CD, Collins V P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N-and/or C-terminal tails. Proc Natl Acad Sci\USA. 1992;89(10):4309-4313.
31. Ruano Y, Mollejo M, Ribalta T, et al. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer. 2006;5:39.
32. Watanabe K, Sato K, Biernat W, et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res. 1997;3(4):523-530.
33. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res. 2009;15(19):6002-6007.
34. Martinez R, Roggendorf W, Baretton G, et al. Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations. Cancer Genet Cytogenet. 2007;175(1):26-34.
35. Chang SM, Parney I F, Huang W, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005;293(5):557-564.
36. Devaux BC, O'Fallon JR, Kelly PJ Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg. May 1993;78(5):767-775.
37. Kleinschmidt-DeMasters BK, Meltesen L, McGavran L, Lillehei KO. Characterization of glioblastomas in young adults. Brain Pathol. 2006;16(4):273-286.
38. Ulutin C, Fayda M, Aksu G, et al Primary glioblastoma multiforme in younger patients: a single-institution experience. Tumori. 2006;92(5):407-411.
39. Hegi ME, Diserens AC, Gorlia T, et al MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997-1003.
40. Sade B, Prayson RA, Lee JH. Gliosarcoma with infratemporal fossa extension. Case report. J Neurosurg. 2006;105(6):904-907.
41. Beaumont TL, Kupsky WJ, Barger GR, Sloan AE. Gliosarcoma with multiple extracranial metastases: case report and review of the literature. J Neurooncol. 2007;83(1):39-46.
42. Matsuyama J, Mori T, Hori S, Nakano T, Yamada A. [Gliosarcoma with multiple extracranial metastases. Case report]. Neurol Med Chir (Tokyo). 1989;29(10):938-943.
43. Witwer B P, Salamat MS, Resnick DK. Gliosarcoma metastatic to the cervical spinal cord: case report and review of the literature. Surg Neurol. 2000;54(5):373-378; discussion 378-379.